Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges

Waleed H Almalki1, Saad Alghamdi2, Abdulaziz Alzahrani3

  • 1Department of Pharmacology and Toxicology, College of Pharmacy, Umm al-qura University, Saudi Arabia.

Drug Discovery Today
|December 31, 2020
PubMed